Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase
Authors:
- Carl P. CiosekCCCarl P. Ciosek
- 1 February 1995
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 34 (2) , 121-137
Abstract
Protein prenylation is increasingly recognized as an important mechanism by which functional association of proteins to membranes is mediated. Ras proteins, regulators of cell proliferation and differentiation, are among the proteins that undergo farnesylation, one of the two prenylation modifications known. Since ras proteins are activated into hyperactive oncogenic versions in a wide variety of human cancers, agents that down modulate ras activity could be antineoplastic. Therefore, inhibitors of farnesyltransferase have the potential to be of therapeutic value as anticancer agents due to their ability to block ras processing and hence its function. We describe the identification of two farnesyl pyrophosphate (FPP) analogs that are potent and selective inhibitors of farnesyltransferase. While showing no toxicity to untransformed cells, a pivaloyloxymethyl ester of one of these inhibitors blocked ras mediated transformation of NIH 3T3 cells. In addition, both the ester and its parent acid inhibited ras farnesylation as measured by incorporation of labeled mevalonate into ras proteins in whole cells. Thus, this is the first report of an FPP analog to show biological activity by inhibiting ras processing in whole cells.Keywords
This publication has 77 references indexed in Scilit:
- The 3Rs of life: Ras, Raf and growth regulationTrends in Genetics, 1994
- Endoproteolysis of non‐CAAX‐containing isoprenylated peptidesFEBS Letters, 1993
- Identification of a Ten-Amino Acid Proline-Rich SH3 Binding SiteScience, 1993
- Substrate specificity of the isoprenylated protein endoproteaseBiochemistry, 1992
- SH2 and SH3 domains: From structure to functionCell, 1992
- Characterization of an acyltransferase acting on p21N-ras protein in a cell-free systemBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Characterization of specific binding sites for [3H]-staurosporine on various protein kinasesBiochemical and Biophysical Research Communications, 1990
- Independent Molecular Pathways in Initiation and Loss of Hormone Responsiveness of Breast CarcinomasScience, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinasesBiochemical and Biophysical Research Communications, 1987